Free Trial

Nature's Sunshine Products (NASDAQ:NATR) Given "Buy" Rating at DA Davidson

Nature's Sunshine Products logo with Medical background

DA Davidson reiterated their buy rating on shares of Nature's Sunshine Products (NASDAQ:NATR - Free Report) in a research note published on Tuesday morning,Benzinga reports. The brokerage currently has a $19.00 price target on the stock.

Nature's Sunshine Products Stock Down 0.3%

Shares of NATR traded down $0.05 during trading hours on Tuesday, hitting $14.51. The company had a trading volume of 34,697 shares, compared to its average volume of 46,124. The firm has a market cap of $266.27 million, a price-to-earnings ratio of 16.49 and a beta of 1.10. Nature's Sunshine Products has a 12 month low of $10.81 and a 12 month high of $18.06. The business has a fifty day moving average of $13.10 and a 200-day moving average of $14.07.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.09. The firm had revenue of $113.25 million for the quarter, compared to analysts' expectations of $109.39 million. Nature's Sunshine Products had a net margin of 3.81% and a return on equity of 11.08%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of NATR. GAMMA Investing LLC raised its holdings in Nature's Sunshine Products by 2,090.2% in the 1st quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after acquiring an additional 2,132 shares during the period. Russell Investments Group Ltd. bought a new position in Nature's Sunshine Products during the fourth quarter worth about $41,000. Amundi bought a new position in Nature's Sunshine Products during the fourth quarter worth about $63,000. Deutsche Bank AG bought a new position in Nature's Sunshine Products during the fourth quarter worth about $103,000. Finally, Wells Fargo & Company MN increased its position in Nature's Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after acquiring an additional 1,611 shares during the period. 79.40% of the stock is owned by institutional investors.

Nature's Sunshine Products Company Profile

(Get Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Articles

Should You Invest $1,000 in Nature's Sunshine Products Right Now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines